Patent · US Active

Method for diagnosing a hemoglobin-related disorder

US9494603B2 · kind B2 · utility

0Cited by

0References

10Claims

0Family size

Assignees

Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
UNIVERSITÉ PARIS-SUD · DE
ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS (APHP) · FR
Université Paris—Est Créteil Val de Marne · FR

Inventors

Veronique Baudin-Creuza · Le Kremlin-Bicêtre, FR
Corinne Vasseur · Le Kremlin-Bicêtre, FR
Frédéric Galacteros · Créteil, FR

Key dates

Filing date	Jun 24, 2015
Grant date	Nov 15, 2016
Priority date	—
Expiry date	Jun 24, 2035

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/56
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention relates to a method for diagnosing, staging and/or monitoring a hemoglobin-related disorder such as β-thalassemia or a treatment against said hemoglobin-related disorder in a subject in need thereof based on the detection and/or quantification the presence of free α-Hb pool in a biological sample obtained from said subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.